Atherosclerotic Renal Disease in Elderly
Keywords:
Abstract
Abstract not found
Downloads
- Article PDF
- TEI XML Kaleidoscope (download in zip)* (Beta by AI)
- Lens* NISO JATS XML (Beta by AI)
- HTML Kaleidoscope* (Beta by AI)
- DBK XML Kaleidoscope (download in zip)* (Beta by AI)
- LaTeX pdf Kaleidoscope* (Beta by AI)
- EPUB Kaleidoscope* (Beta by AI)
- MD Kaleidoscope* (Beta by AI)
- FO Kaleidoscope* (Beta by AI)
- BIB Kaleidoscope* (Beta by AI)
- LaTeX Kaleidoscope* (Beta by AI)
How to Cite
References
Bax L, van Y, Rabelink AJ, Algra A, Beutler JJ, Mali WP (2003) Influence of atherosclerosis on agerelated changes in renal size and function Eur J Clin Invest. 33(1), 34-40. https://doi.org/10.1046/j.1365-2362.2003.01091.x
Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, Ellis SG, Lincoff AM, Topol EJ (2003) Prevalence of conventional risk factors in patients withcoronary heart disease. 290, 898-904.
Russell Ross (1999) Atherosclerosis-an inflammatory disease N Engl J Med. 340(2), 115-126. https://doi.org/10.1056/nejm199901143400207
(2003) USRDS 2003 Annual Data Report; Atlas of End-Stage Renal Disease in the United States.
Amann K, Tyralla K, Gross ML, Eifert T, Adamczak M, Ritz E (2003) Special characteristics of atherosclerosis in chronic renal failure. 60(suppl 1).
A. Shurrab, P. MacDowall, J. Wright, H. Mamtora, P. Kalra (2003) The Importance of Associated Extra-Renal Vascular Disease on the Outcome of Patients with Atherosclerotic Renovascular Disease.
Takeji Uzu T, Fujii Yamada N, Takishita Yamauchi A, Kimura G.Prevalence (2002) Prevalence and outcome of renal artery stenosis in atherosclerotic patients with renal dysfunction. 25, 537-542.
Kimberley Hansen, Matthew Edwards, Timothy Craven, Gregory Cherr, Sharon Jackson, Richard Appel, Gregory Burke, Richard Dean (2002) Prevalence of renovascular disease in the elderly: a population-based study J Vasc Surg. 36(3), 443-451. https://doi.org/10.1067/mva.2002.127351
V. Kamanna, D. Roh, M. Kirschenbaum (1998) Hyperlipidemia and kidney disease: concepts derived from histopathology and cell biology of the glomerulus Histol Histopathol. 13, 169-179.
Christine Abrass (2004) Cellular lipid metabolism and the role of lipids in progressive renal disease Am J Nephrol. 24(1), 46-53. https://doi.org/10.1159/000075925
McMahan McGill HC Jr, Oalmann Tracy RE, Herderick Cornhill JF, Strong JP (1998) Relation of a postmortem renal index of hypertension to atherosclerosis and coronary artery size in young men and women. 18, 1108-1118.
V. Kumar, R. Cotran, S. Robbins (2003) Basic Pathology.
I. Angiotensin (1996) Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. 97.
(2005) Kalra PA, Guo H, Kausz AT, et al. Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. 68(1), 293-301. https://doi.org/10.1111/j.1523-1755.2005.00406.x
J. Scoble, G. Hamilton (1990) Atherosclerotic renovascular disease. 300(6741), 1670. https://doi.org/10.1136/bmj.300.6741.1670
Richard Appel, Anthony Bleyer, Scott Reavis, Kimberley Hansen (1995) Appel RG, Bleyer AJ, Reavis S, Hansen KJ. Renovascular disease in older patients beginning renal replacement therapy. 48(1), 171-176. https://doi.org/10.1038/ki.1995.281
J. Am (1994) Mailloux LU, Napolitano B, Bellucci AG, et al. Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20- year clinical experience. 24(4), 622-629. https://doi.org/10.1016/s0272-6386(12)80223-x
van JM, Penne EL, Beek FJ (2003) Prevalence of atherosclerotic renal artery stenosis in patients starting dialysis. 18(6), 1147. https://doi.org/10.1093/ndt/gfg121
Choudhri AH, Cleland JG, Rowlands PC (1990) Unsuspected renal artery stenosis in peripheral vascular disease. 301(6762), 1197. https://doi.org/10.1136/bmj.301.6762.1197
Trude Leertouwer, Peter Pattynama, Annette Van Den Berg-Huysmans (2001) Leertouwer TC, Pattynama PM, van den Berg- Huysmans A. Incidental renal artery stenosis in peripheral vascular disease: a case for treatment?. 59(4), 1480-1483. https://doi.org/10.1046/j.1523-1755.2001.0590041480.x
Kim D, Porter DH, Brown R (1991) Renal artery imaging: a prospective comparison of intra-arterial digital subtraction angiography with conventional angiography. 42, 345e357.
Plouin PF, Darne´ B, Chatellier G (1993) Restenosis after a first percutaneous transluminal renal angioplasty. 21, 89e96.
B. van Jaarsveld, H. Pieterman, L. van Dijk (1999) Interobserver variability in the angiographic assessment of renal artery stenosis.
Rountas C, Vlychou M, Vassiou K (2007) Imaging modalities for renal artery stenosis in suspected renovascular hypertension: prospective intraindivi dual comparison of color Doppler US, CT angiography, GD-enhanced MR angiography, and digital substraction angiography. 29, 295e302.
Li JC, Jiang YX, Zhang SY (2008) Evaluation of renal artery stenosis with hemodynamic parameters of Doppler sonography. 48, 323 e328.
J. Radermacher, A. Chavan, J. Scha¨ ffer (2000) Transplanted Renal Artery: Detection of Stenosis with Color Doppler US.
Hua HT, Hood DB, Jensen CC, Hanks SE, Weaver FA (2000) The use of colorflow duplex scanning to detect significant renal artery stenosis. 14, 118e124.
Olin JW, Piedmonte MR, Young JR, DeAnna S, Grubb M, Childs MB (1995) The utility of duplex ultrasound scanning of the renal arteries for diagnosing significant renal artery stenosis. 122, 833e838.
Vasbinder GB, Nelemans PJ, Kessels AG (2001) Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. 135, 401e411.
K. Kent, EdelmanRR, KimD (1991) Kent KC,EdelmanRR,KimD, et al.Magnetic resonanceimaging: a reliable test for the evaluation of proximal atherosclerotic renal arterial stenosis.
Wilcox CS (1993) Use of angiotensin-converting-enzyme inhibitors for diagnosing renovascular hypertension. 44, 1379e1390.
Svetkey LP, Kadir S, Dunnick NR (1991) Svetkey LP, Kadir S, Dunnick NR, et al. 17, 678.
E. Pedersen (1994) Pedersen EB. Angiotensin-converting enzyme inhibitor renography. Pathophysiological, diagnostic and therapeutic aspects in renal artery stenosis. 9(5), 482-492. https://doi.org/10.1093/ndt/9.5.482
Simon G, Coleman CC (1994) Captopril-stimulated renal vein renin measurements in the diagnosis of atheroscleroticrenovascular hypertension. 7, 1e6.
Balk E, Raman G, Chung M (2006) Effectiveness of management strategies for renal artery stenosis: a systematic review. 145(12), 901. https://doi.org/10.7326/0003-4819-145-12-200612190-00143
Dworkin LD, Jamerson KA (2007) Is renal artery stenting the correct treatment of renal artery stenosis? Case against angioplasty and stenting of atherosclerotic renal artery stenosis. 115, 271.
Newman AB, Naydeck BL, Sutton-Tyrrell K (2001) The role of comorbidity in the assessment of intermittent claudication in older adults. 54(3), 294. https://doi.org/10.1016/s0895-4356(00)00308-5
Kannel WB, Skinner Jr, Schwartz MJ, Shurtleff D (1970) Intermittent claudication. Incidence in the Framingham Study. 41, 875.
W. Kannel, D. McGee (1985) Update on Some Epidemiologic Features of Intermittent Claudication: The Framingham Study.
O'Hare AM, Bertenthal D, Shlipak MG (2005) Impact 33:13. of renal insufficiency on mortality in advanced lower extremity peripheral arterial disease. 16(2), 514. https://doi.org/10.1681/asn.2004050409
Diehm C, Schuster A, Allenberg JR (2004) High prevalence of peripheral arterial disease and comorbidity in 6880 primary care patients: crosssectional study. 172(1), 95. https://doi.org/10.1016/s0021-9150(03)00204-1
N. Marcussen (1991) Marcussen N. Atubular glomeruli in renal artery stenosis. 65, 558.
Luan Truong, Anwar Farhood, Jerry Tasby, David Gillum (1992) Truong LD, Farhood A, Tasby J, Gillum D. Experimental chronic renal ischemia: morphologic and immunologic studies. 41(6), 1676-1689. https://doi.org/10.1038/ki.1992.241
Novick AC, Ziegelbaum M, Vidt DG (1987) Trends in surgical revascularization for renal artery disease. Ten years' experience. 257, 498.
Modrall JG, Rosero EB, Smith ST (2008) Operative mortality for renal artery bypass in the United States: Results from the National Inpatient Sample. 48(2), 317. https://doi.org/10.1016/j.jvs.2008.03.014
van PJ, Beutler JJ, Kaatee R (1995) Transluminal vascular stent for ostial atherosclerotic renal artery stenosis. 346(8976), 672. https://doi.org/10.1016/s0140-6736(95)92283-0
Burket MW, Cooper CJ, Kennedy DJ (2000) Renal artery angioplasty and stent placement: predictors of a favorable outcome. 139(1), 64. https://doi.org/10.1016/s0002-8703(00)90310-7
(1997) Harden PN, MacLeod MJ, Rodger RS, et al. Effect of renal-artery stenting on progression of renovascular renal failure. 349(9059), 1133-1136. https://doi.org/10.1016/s0140-6736(96)10093-3
Rees CR, Palmaz JC, Becker GJ (1991) Palmaz stent in atherosclerotic stenoses involving the ostia of the renal arteries: preliminary report of a multicenter study. 181(2), 507. https://doi.org/10.1148/radiology.181.2.1924796
C. Isles, S. Robertson, D. Hill (1999) Management of renovascular disease: a review of renal artery stenting in ten studies. 92(3), 159. https://doi.org/10.1093/qjmed/92.3.159
Creager M, Dzau VJ, Loscalzo J (2006) Atheroembolism.
Thadhani RI, Camargo Jr, Xavier RJ (1995) Atheroembolic renal failure after invasive procedures. Natural history based on 52 histologically proven cases. 74(6), 350. https://doi.org/10.1097/00005792-199511000-00005
C. Mannesse, P. Blankestijn, Man in 't Veld, A. Schalekamp, M. (1991) Mannesse CK, Blankestijn PJ, Man in 't Veld AJ, Schalekamp MA. Renal failure and cholesterol crystal embolization: a report of 4 surviving cases and a review of the literature. 36, 240.
J. Am (2000) Scolari F, Tardanico R, Zani R, et al. Cholesterol crystal embolism: A recognizable cause of renal disease. 36(6), 1089-1109. https://doi.org/10.1053/ajkd.2000.19809
Kulwant Modi, Venkateswara Rao (2001) Modi KS, Rao VK. Atheroembolic renal disease. 12(8), 1781-1787. https://doi.org/10.1681/asn.v1281781
Fukumoto Y, Tsutsui H, Tsuchihashi M (2003) The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. 42, 211.
(2007) Scolari F, Ravani P, Gaggi R, et al. The challenge of diagnosing atheroembolic renal disease: clinical features and prognostic factors. 116, 298.
Scolari F, Ravani P, Pola A (2003) Predictors of renal and patient outcomes in atheroembolic renal disease: a prospective study. 14(6), 1584. https://doi.org/10.1097/01.asn.0000069220.60954.f1
Xavier Belenfant, Alain Meyrier, Christian Jacquot (1999) Belenfant X, Meyrier A, Jacquot C. Supportive treatment improves survival in multivisceral cholesterol crystal embolism. 33(5), 840-850. https://doi.org/10.1016/s0272-6386(99)70415-4
Francesco Scolari, Pietro Ravani (2010) Scolari F, Ravani P. Atheroembolic renal disease. 375(9726), 1650-1660. https://doi.org/10.1016/s0140-6736(09)62073-0
Meyrier A, Buchet P, Simon P (1988) Atheromatous renal disease. 85, 139.
Hyman BT, Landas SK, Ashman RF (1987) Warfarinrelated purple toes syndrome and cholesterol microembolization. 82, 1233.
Bharat Gupta, Bruce Spinowitz, Chaim Charytan, Samuel Wahl (1993) Gupta BK, Spinowitz BS, Charytan C, Wahl SJ. Cholesterol crystal embolization-associated renal failure after therapy with recombinant tissue-type plasminogen activator. 21(6), 659-662. https://doi.org/10.1016/s0272-6386(12)80040-0
P. Tunick, A. Nayar, G. Goodkin (2002) Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque. 90, 1320.
(1998) Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. 128(8), 639. https://doi.org/10.7326/0003-4819-128-8-199804150-00005
(1994) Baumann DS, McGraw D, Rubin BG, et al. An institutional experience with arterial atheroembolism. 8(3), 258-265. https://doi.org/10.1007/bf02018173
Sharma PV, Babu SC, Shah PM, Nassoura ZE (1996) Changing patterns of atheroembolism. 4, 573.
Michael Fine, Wishwa Kapoor, Vincent Falanga (1987) Fine MJ, Kapoor W, Falanga V. Cholesterol crystal embolization: a review of 221 cases in the English literature. 38(10), 769-784. https://doi.org/10.1177/000331978703801007
Lye WC, Cheah JS, Sinniah R Renal cholesterol embolic disease. Case report and review of the.
Smith MC, Ghose MK, Henry AR (1981) The clinical literature. Am J Nephrol 1993; 13:489. spectrum of renal cholesterol embolization. 71, 174.
Syed Haqqie, Rodrigo Urizar, Jaswant Singh (1996) Haqqie SS, Urizar RE, Singh J. Nephrotic-range proteinuria in renal atheroembolic disease: report of four cases. 28(4), 493-501. https://doi.org/10.1016/s0272-6386(96)90458-8
J. Am (1997) Greenberg A, Bastacky SI, Iqbal A, et al. Focal segmental glomerulosclerosis associated with nephrotic syndrome in cholesterol atheroembolism: clinicopathological correlations. 29(3), 334-344. https://doi.org/10.1016/s0272-6386(97)90193-1
Richards am, Eliot rs, Kanjuh vi (1965) cholesterol embolism: a multiple-system disease masquerading as polyarteritis nodosa. 15, 696.
Mark Haas, Benjamin Spargo, Ernst-Jan Wit, Shane Meehan (2000) Haas M, Spargo BH, Wit EJ, Meehan SM. Etiologies and outcome of acute renal insufficiency in older adults: a renal biopsy study of 259 cases. 35(3), 433-447. https://doi.org/10.1016/s0272-6386(00)70196-x
F. Cosio, R. Zager, H. Sharma (1985) ATHEROEMBOLIC RENAL DISEASE CAUSES HYPOCOMPLEMENTAEMIA*1. 326(8447), 118-121. https://doi.org/10.1016/s0140-6736(85)90225-9
Balakuntalam Kasinath, E. Lewis (1987) Kasinath BS, Lewis EJ. Eosinophilia as a clue to the diagnosis of atheroembolic renal disease. 147(8), 1384. https://doi.org/10.1001/archinte.1987.00370080020004
Scolari F, Ravani P, Gaggi R (2007) The challenge of diagnosing atheroembolic renal disease: clinical features and prognostic factors. 116, 298.
Published
2014-08-11
Issue
Section
License
Copyright (c) 2014 Authors and Global Journals Private Limited

This work is licensed under a Creative Commons Attribution 4.0 International License.